Nitric oxide-endothelin-1 interaction in humans

Journal of Applied Physiology

Volumn 82, Issue 5, 1997, Pages 1593-1600

  Ahlborg, Gunvor ^a   Lundberg, Jan M ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

arterial levels and pulmonary release of endothelin 1; cardiac output; insulin and splanchnic glucose output; N(G) monomethyl L arginine and endothelin 1 infusion; splanchnic and renal blood flow; systemic and pulmonary vascular resistance

Indexed keywords

ENDOTHELIN 1; GLUCAGON; GLUCOSE; INSULIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; GLUCOSE METABOLISM; HEART OUTPUT; HEART RATE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTERACTION; SPLANCHNIC BLOOD FLOW; VASCULAR RESISTANCE;

EID: 0031010719     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.82.5.1593     Document Type: Article

References (38)

1. Ahlborg, G., E. Weitzberg, and J. M. Lundberg. The effect of endothelin-1 infusion on splanchnic glucose production and glucagon levels in humans. J. Appl. Physiol. 77: 121-126, 1994.
2. Ahlborg, G., E. Weitzberg, and J. M. Lundberg. Metabolic and vascular effects of circulating endothelin-1 infusion during moderately heavy prolonged exercise. J. Appl. Physiol. 78: 2294-2300, 1995.
3. Ahlborg, G., E. Weitzberg, and J. M. Lundberg. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans. J. Appl. Physiol. 79: 141-145, 1995.
4. Bachman, S., H. M. Bosse, and P. Mundel. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F885-F898, 1995.
5. Barcroft, H. Circulation in skeletal muscle. In: Handbook of Physiology. Circulation. Washington, DC: Am. Physiol. Soc., 1963, sect. 2, vol. 2, chapt. 40, p. 1353-1385.
6. Barer, G., C. Emery, A. Stewart, D. Bee, and P. Howard. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J. Physiol. (Lond.) 463: 1-16, 1993.
7. Bilski, J., J. W. Konturek, S. J. Konturek, and W. Domschke. The involvement of endogenous nitric oxide in vagal-cholinergic stimulation of exocrine and endocrine pancreas in dogs. Int. J. Pancreatol. 18: 41-49, 1995.
8. Boulanger, C., and T. F. Lüscher. Release of endothelin from the procine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587-590, 1990.
9. Brady, A. J. B., J. B. Warren, P. A. Poole-Wilson, T. J. Williams, and S. E. Harding. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H176-H182, 1993.
10. Castillo, L., T. C. de Rojas, T. E. Chapman, J. Vogt, J. F. Burke, S. R. Tannenbaum, and V. R. Young. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc. Natl. Acad. Sci. USA 90: 193-197, 1993.
11. De Nucci, G., R. Thomas, P. D'Orleans-Juste, E. Antunes, C. Walder, T. D. Warner, and J. R. Vane. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA 85: 9797-9800, 1988.
12. Frostell, C., M.-D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. Inhaled nitric oxide, a selective pulmonary vasodilator reversing hypoxic, pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
13. Frostell, C. G., H. Blomqvist, G. Hedenstierna, J. M. Lundberg, W. M. Zapol. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427-435, 1993.
14. Furchgott, R. F., and J. V. Zawadski. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
15. Haynes, W. G., J. P. Noon, B. R. Walker, and D. J. Webb. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J. Hypertens. 11: 1375-1380, 1993.
16. Hemsén, A., J. Pernow, and J. M. Lundberg. Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig. Acta Physiol. Scand. 141: 325-334, 1991.
17. Ignarro, L. J., P. A. Bush, and G. M. Buga. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun. 170: 843-850, 1990.
18. Jones, P. M., S. J. Persaud, T. Bjaaland, J. D. Pearson, and S. L. Howell. Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans. Diabetologia 35: 1020-1027, 1992.
19. Kiowski, W., G. Sütsch, P. Hunziker, P. Müller, J. Kim. E. Oechslin, R. Schmitt, R. Jones, and O. Bertel. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346: 732-736, 1995.
20. Moncada, S., R. M. C. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
21. Moore, F. D., K. H. Olesen, J. D. McMurrey, H. V. Parker, M. R. Ball, and C. M. Boyden. The Body Cell Mass and Its Supporting Environment. Philadelphia, PA: Saunders, 1963, p. 58-173.
22. Palmer, R. M. J., D. S. Ashton, and S. Moncada. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
23. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
24. Palmer, R. M. J., D. D. Rees, D. S. Ashton, S. Moncada. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153: 1251-1256, 1988.
25. Richard, V., M. Hogie, M. Clozel, B. M. Loffler, and C. Thuillez. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91: 771-775, 1995.
26. Rossaint, R., K. J. Falke, F. Lópes, K. Slama, U. Pison, and K. J. Falke. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328: 399-405, 1993.
27. Saijonmaa, O., A. Ristimäki, and F. Fyhrquist. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem. Biophys. Res. Commun. 173: 514-520, 1990.
28. Vallance, P., J. Collier, and S. Moncada. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997-1000, 1989.
29. Vallance, P., A. Leone, A. Calver, J. Collier, and S. Moncada. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992.
30. Wagner, O. F., G. Christ, J. Wojta, H. Vierhapper, S. Parzer, P. J. Nowotny, B. Schneider, W. Waldhäusl, and B. R. Binder. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 267: 16066-16068, 1992.
31. Warner, T. D., J. A. Mitchell, G. de Nucci, and J. R. Vane. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J. Cardiovasc. Pharmacol. 13, Suppl. 5: S85-S88, 1989.
32. Weitzberg, E., G. Ahlborg, and J. M. Lundberg. Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues. Biochem. Biophys. Res. Commun. 180: 1298-1303, 1991.
33. Weitzberg, E., G. Ahlborg, and J. M. Lundberg. Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle. Clin. Physiol. 13: 653-662, 1993.
34. Whittle, B. J. R., and S. Moncada. Nitric oxide: the elusive mediator of the hyperdynamic circulation of cirrhosis? Hepatology 16: 1089-1092, 1992.
35. Winer, B. Statistical Principles in Experimental Design. New York: McGraw-Hill, 1971, p. 199.
36. Yanagisawa, M., A. Inoue, Y. Takuwa, Y. Mitsui, M. Kobayashi, and T. Masaki. The human preproendothelin-1 gene: possible regulation by endothelial phosphoinositide turnover signaling. J. Cardiovasc. Pharmacol. 13: S13-S17, 1989.
37. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
38. Yokokawa, K., M. Kohno, K. Yasunari, K. Murakawa, and T. Takeda. Endothelin-3 regulated endothelin-1 production in cultured human endothelial cells. Hypertension Dallas 18: 304-315, 1991.